RAC 3.03% $1.70 race oncology ltd

General Comments / Chat, page-11052

  1. 929 Posts.
    lightbulb Created with Sketch. 546
    Agreed.
    After all the turmoil of H1 2023, I feel Race turned a corner since October/November last year.
    You look at all the developments and announcements, since then it's been block by block adding value to the company.
    Could have gone either way, but the biggest hurdle of RC220 has been cleared. Lot of hard work would have gone into making sure this was accomplished within the stated timelines. Perhaps it has something to do with the united team working for the best outcome.
    Funding has been secured successfully.
    Lots to look forward to this year with the start of CPACS trial.

 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.